Case File
efta-efta01446898DOJ Data Set 10CorrespondenceEFTA Document EFTA01446898
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01446898
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
To:
Jeffrey Epstein
Tazia Smith/db/dbcom@DBAMERICAS,
01/17/2014 11:15 AM
Subject:
Re: Trade Idea: Long 3-Month
uSDCAD KI call spread - 1.10 with a 1.13 sold call knocking-in only if uSDCAD trades to 1.17 [I]
i like it
.. size ?
On Fri, Jan 17, 2014 at 11:48 AM, Tazia Smith c
> wrote:
Classification: For internal use only
Jeffrey -
our us FX traders agree/like Nav's call here. The 3-month 1.10/1.13 USDCAD, 1.17 knock-in call
spread (where that 1.13 short call only exists if uSDCAD goes to 1.17 during the life of the trade)
described below is currently offered -1.1% (Source: DB FX Sales, 1/17/14). Please see the investment
thesis below and let us know your thoughts.
Best,
Tazia
Indicative levels only. Subject to market movement. Source: DB Key Client Partners London, as of
1/17/14.
Forwarded by Tazia Smith/db/dbcom on 01/17/2014 10:35 AM
From:
Gupta/db/dbcom@DBEMEA
To:
07:35 AM
Subject:
USDCAD calls to position for further weakness in CAD.
Nav
kcp-
01/17/2014
I like buying
spot FX is currently 1.095. [I]
Classification: For internal use only
I like uSDCAD call options to position for further weakness in CAD. Spot FX is currently 1.095.
Over the course of the past week the interest rate curve has started pricing in a small amount of
rate cuts - this development is significant and clearly a beginning of a pain trade. I believe it can go
further. Lower CAD rates from here will drive USD CAD higher.
.cmime-attachment.gif›.
The limited downside play I like best in USDCAD is buying a 3month expiry 1.10 / 1.13 call spread
on USDCAD but where the short 1.13 call position only exists (knocks-in) if USD trades at 1.17 trades in
the market before the option expires, otherwise the option payoff is the same as a 1.10 call option.
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
DB-SDNY-0101331
CONFIDENTIAL
SDNY_GM_00247515
EFTA01446898
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.